Dr. Geetha Manjunath

Founder, CEO and CTO NIRAMAI Health Analytix

Dr. Geetha Manjunath is the Founder, CEO and CTO of NIRAMAI Health Analytix, who has led the company to develop a breakthrough solution for detecting early stage breast cancer using Artificial Intelligence.

Through this work, Niramai has become the first Indian company to obtain medical device regulatory clearances of both US FDA and CE Mark for Europe for women health radiology product. This device which uses AI on medical images has put Niramai and India on the Top 100 AI Startups in the world.

Geetha holds a PhD from The Indian Institute of Science in Computer Science and management education from Kellogg's Chicago. She has proposed and led multiple AI projects at Xerox Research and Hewlett Packard India. Before starting NIRAMAI, Geetha was a Lab Director for Data Analytics Research at Xerox India.

Geetha has received many international and national recognition for her innovations and entrepreneurial work, including CSI Gold Medal, BIRAC WinER Award 2018 and is also on the Forbes List of Top 20 Self-Made Women 2020.

She was recently awarded the Accenture Vahini Innovator of the Year Award from Economic Times and Women Entrepreneur of the Year 2020 by BioSpectrum India. Geetha is also an inventor of 18 US patents and more pending grant.

9:30 - 10:15 hrs.

Tuesday 13th December

Future of Cancer Care with AI

Breast Cancer is completely curable, still 90 thousand women every year are dying in India. While in US and other places there is a 90% survival rate, India has only a 50% survival rate.

Having said that, “early detection” is the key. The diseased can become completely normal but that is not happening at present.